PATENT CLAIM ANALYSIS

Application Number: 16007102
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["424", "142100"]

Abstract:
The present invention relates to pharmaceutical formulations of a pharmaceutically active antigen binding protein, for example a monoclonal antibody. Such formulations comprise, in addition to the antigen binding protein, a buffering agent and a tonicity agent.

Claim (Index 1):
A pharmaceutical formulation for an antigen binding protein comprising:\n a. 200 mg/mL antigen binding protein; b. 10 mM of a buffering agent which is histidine providing a pH of 6.0\u00b10.5; c. 115 mM of a tonicity agent which is sodium chloride; d. 25 mM of a stabilizer which is L-arginine hydrochloride; and e. 0.01% (w/v) of a nonionic surfactant which is polysorbate 80; wherein the antigen binding protein is a monoclonal antibody or fragment thereof and comprises amino acid sequences CDRH1 of SEQ ID NO:11, CDRH2 of SEQ ID NO: 12, CDRH3 of SEQ ID NO:13, CDRL1 of SEQ ID NO:14, CDRL2 of SEQ ID NO:15, and CDRL3 of SEQ ID NO:16.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 94.0
- Lexical Diversity: 1.41379
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15311223', '14506576', '12325049', '13774735', '15950974']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6869706809963303
- 35 USC 102 Novelty (BERT): 0.5552128630266665
- Combined Prediction Score: 0.6737948991993639
- Mean Citation Score: 273.771974
- Max Citation Score: 407.2216
- Similarity Product: 361.1463932385922

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test